Lilly Diabetes invites you to listen to a podcast about Trulicity® (dulaglutide):

Putting the Results Into Perspective: Trulicity’s Cardiovascular Outcomes Trial (REWIND)

In this podcast episode, Dr. Eden Miller and Dr. Matthew Budoff discuss the relationship between type 2 diabetes and CV risk, the importance of addressing both hyperglycemia and CV risk in patients with type 2 diabetes, and treatment considerations for these patients. They will also discuss the design and results of the Trulicity CV outcomes trial, REWIND. 

Please see full Prescribing Information, including Boxed Warning about possible thyroid tumors including thyroid cancer, Medication Guide and Instructions for Use.

See omnystudio.com/listener for privacy information.